Cardio Pharm Flashcards
Thiazides MOA
” - Block reapsorption of Na+ and Cl- in distal tubule
- Thiazides secreted at proximal tubule into lumen of nephron, travel to distal tubule
- Decreases Cardiac Preload”
Thiazides Clinical Uses
” - 1st Line for Primary Hypertension
- Prevention of Kidney Stones
- Nephogenic Diabetes Inspidius”
Thiazide Contraindications
” - Contraindications
- Sulfa Allergy
- Severe Hypokalemia
- Interactions
- Diabetes Mellitus
- ACE inhibitors
- NSAIDs
- May not work in severe renal disease”
Thiazide Adverse indications
” - Electrolyte disturbances – decreased Na, Mg, K, Cl,
- Hypercalcemia
- Hyperuricemia (gout patients)
- Hyperglycemia (diabetics)
- Increased BUN/Creatinine ratio > 20:1 (dehydration)
- Cholesterol elevation
- Idiopathic: thrombocytopenia, pancreatitis”
Loops MOA
” - Blocks reabsorption of Na+ and Cl- in thick acending limb of Loop of Henle
- Decreases Cardiac Preload”
Loops Clinical Uses
” - 2nd Line for Primary HTN
- Acute & Congestive Heart Failure
- Renal/CKD Failure”
Loop contraindication
” - Contraindications
- Sulfa Allergy except Ethacrynic Acid”
Loop adverse effects
” - Electrolyte disturbances – decreased K, Na, Mg, Cl
- Hypocalcemia
- Hyperuricemia (gout patients)
- Increased glucose (diabetic patients)
- Increased BUN/Creatinine ratio > 20:1 (dehydration)
- Ototoxicity
- Idiopathic: thrombocytopenia, pancreatitis”
Examples of loops
” - Bumetanide
- Furosemide
- Torsemide
- Ethacrynic Acid”
Potassium sparing MOA
” - Direct inhibition of ENaC in distal convoluted tubule
- Reduced Na+ reabsopriton and reduced K+ secretion
- Decrease Cardaic Preload”
Potassium sparing clinical uses
” - Hypertension with Hypokalemia
- Ascites/Edema
- Additive Effect in Combo with Thiazide or Loop Diuretic”
Potassium sparing adverse interactions
” - Contraindications
- Anuria
- Hyperkalemia
- Addison Disease
- Significant Chronic Kidney Disase (GFR < 45 mL/min)
- Interactions
- Hyperkalemia with other diuretics
- Do not use as monotherapy for hypertension”
Potassium sparing adverse effects
” - Hyperkalemia
- Arrythymias
- GI Disturbaces”
Contraindicatiosn of potassium spairing
amiloride contraindicated in diabetic nephropathy
Sprionolactone MOA
” - Competitively binds to aldosterone receptors in late distal convoluted tubule.
- Inhibits effects of aldosterone leading to decreased Na+ reabsorption & K+ excretion
- Decreased Mortaility
- Decrease Cardiac Preload”
Sipironolactone uses
” - Hypertension with Hypokalemia
- Ascites/Edema
- Additive Effect in Combo with Thiazide or Loop Diuretic
- Systolic Heart Failure another standard therapy
- Should be considered for pts after MI with acute heart failure”
Contraindications Spironolactone
” - Contraindications
- Anuria
- Hyperkalemia
- Addison Disease
- Interactions
- Caution in pts with decreased renal function
- Hyperkalemia with other diruetics”
Spironolactone AE
” - Spironolactone: can cause gynecomastia in men & amenorrhea in women
- Eplerenone: use caution with other CYP3A4 inhibitors, & diabetics”
ACE inhibitors MOA
” - Inhibits angiotensin converting enzyme, preventing formation of angiotensin II inhibiting downstream effects of RAAS
- Decreased secretion of aldosterone
- Decreased Cardiac Afterload & Preload
- Decreased Cardaic Remodeling”
ACE inhibitor clinical uses
” - 1st Line HTN Therapy for
- Diabetes - Ischemic/Coronary Heart Disease - Systolic Heart Failure (HFrEF) (mortality benefit) - History of MI - Scleroderma"
Contraindications of ACE/ interactions
” - Contraindications
- Pregnancy
- Not first line or monotherapy for African American patients
- Other ARBs or direct renin inhibitors
- C1 esterase inhibitor defiency
- Aortic Stenosis
- Interactions
- NSAIDS (can causes Acute Kidney Injury)
- Caution with preexisting kidney disease”
AE of ACEI
” - Cough - due to bradykinin disruption
- Hyperkalemia
- Orthostatic Hypotension
- Azotemia
- Skin Rash
- Decrease GFR
- Angioedema (Rare) - if occurs switch to ARB however be aware of an 8-10% cross reactivity”
ARB MOA
” - Antagonist at the angiotensin II receptor, preventing downstream effects of RAAS
- Decreased sectretion of aldosterone but increased renin secretion
- Decreased Cardiac Preload & Afterload
- Decreased Cardiac Remodeling”
Clinical Use ARB
- 2nd Line Therapy if ACE Inhibitors aren’t tolerated